Search
Dyne Therapeutics Inc
DYNAdd to Watchlist
25.180USD
-0.550-2.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.16BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Mon, May 11
Updated: Mon, May 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
16.08%
Janus Henderson Investors
8.40%
BlackRock Institutional Trust Company, N.A.
5.73%
Atlas Venture
5.52%
State Street Investment Management (US)
4.05%
Other
60.22%
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
16.08%
Janus Henderson Investors
8.40%
BlackRock Institutional Trust Company, N.A.
5.73%
Atlas Venture
5.52%
State Street Investment Management (US)
4.05%
Other
60.22%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.18%
Investment Advisor/Hedge Fund
28.62%
Hedge Fund
15.07%
Venture Capital
13.71%
Private Equity
5.35%
Research Firm
2.66%
Pension Fund
0.55%
Individual Investor
0.37%
Bank and Trust
0.36%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
493
190.35M
115.28%
-7.82M
2025Q4
448
158.30M
107.46%
+27.45K
2025Q3
454
158.31M
108.39%
+22.59M
2025Q2
434
130.55M
101.97%
+5.93M
2025Q1
429
124.85M
105.00%
+6.07M
2024Q4
402
113.11M
119.02%
-398.28K
2024Q3
386
113.48M
117.07%
+1.31M
2024Q2
363
112.24M
104.57%
+15.20M
2024Q1
314
96.67M
85.15%
+22.52M
2023Q4
273
71.44M
122.70%
+4.09M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
T. Rowe Price Investment Management, Inc.
26.58M
16.11%
+9.04M
+51.53%
Feb 28, 2026
Janus Henderson Investors
13.89M
8.42%
-857.78K
-5.82%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
9.48M
5.74%
+1.46M
+18.19%
Dec 31, 2025
Atlas Venture
9.13M
5.53%
--
--
Dec 31, 2025
State Street Investment Management (US)
6.69M
4.06%
+1.42M
+27.02%
Dec 31, 2025
Fidelity Management & Research Company LLC
6.57M
3.98%
+1.17M
+21.63%
Dec 31, 2025
Adage Capital Management, L.P.
5.17M
3.13%
+1.62M
+45.53%
Dec 31, 2025
Orbis Investment Management Ltd.
4.80M
2.91%
+4.80M
--
Dec 31, 2025
Forbion Capital Partners
5.46M
3.31%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
4.03%
State Street SPDR S&P Biotech ETF
1.18%
Virtus LifeSci Biotech Clinical Trials ETF
1.06%
JPMorgan Healthcare Leaders ETF
0.73%
Direxion Daily S&P Biotech Bull 3X Shares
0.72%
ProShares Ultra Nasdaq Biotechnology
0.38%
JPMorgan Fundamental Data Science Small Core ETF
0.35%
Optimize Strategy Index ETF
0.35%
Invesco Nasdaq Biotechnology ETF
0.31%
iShares Health Innovation Active ETF
0.29%
View more
iShares Neuroscience and Healthcare ETF
Proportion4.03%
State Street SPDR S&P Biotech ETF
Proportion1.18%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.06%
JPMorgan Healthcare Leaders ETF
Proportion0.73%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0.72%
ProShares Ultra Nasdaq Biotechnology
Proportion0.38%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.35%
Optimize Strategy Index ETF
Proportion0.35%
Invesco Nasdaq Biotechnology ETF
Proportion0.31%
iShares Health Innovation Active ETF
Proportion0.29%